Citadel Advisors
CVS icon

Citadel Advisors’s CVS Health CVS Stock Holding History

Citadel Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$176M Sell
2,452,800
-1,235,900
-34% -$95.2M 0.03% 507
2025
Q4 		$293M Sell
3,688,700
-456,200
-11% -$36M 0.04% 351
2025
Q3 		$312M Buy
4,144,900
+719,400
+21% +$49.3M 0.05% 319
2025
Q2 		$236M Sell
3,425,500
-556,300
-14% -$36.5M 0.04% 353
2025
Q1 		$270M Buy
3,981,800
+287,100
+8% +$17.2M 0.05% 275
2024
Q4 		$166M Buy
3,694,700
+1,198,600
+48% +$67.2M 0.03% 484
2024
Q3 		$157M Sell
2,496,100
-225,700
-8% -$13.2M 0.03% 466
2024
Q2 		$161M Sell
2,721,800
-948,100
-26% -$59.3M 0.03% 434
2024
Q1 		$293M Buy
3,669,900
+1,490,600
+68% +$114M 0.06% 248
2023
Q4 		$172M Sell
2,179,300
-2,304,500
-51% -$164M 0.03% 415
2023
Q3 		$313M Buy
4,483,800
+1,274,300
+40% +$90.3M 0.07% 181
2023
Q2 		$222M Buy
3,209,500
+835,900
+35% +$59.5M 0.05% 285
2023
Q1 		$176M Buy
2,373,600
+296,000
+14% +$24.8M 0.04% 372
2022
Q4 		$194M Buy
2,077,600
+250,900
+14% +$24.2M 0.05% 346
2022
Q3 		$174M Buy
1,826,700
+90,700
+5% +$8.98M 0.04% 364
2022
Q2 		$161M Sell
1,736,000
-266,400
-13% -$26M 0.04% 363
2022
Q1 		$203M Sell
2,002,400
-374,100
-16% -$39.3M 0.04% 338
2021
Q4 		$245M Sell
2,376,500
-25,200
-1% -$2.33M 0.05% 275
2021
Q3 		$204M Buy
2,401,700
+242,400
+11% +$20.3M 0.04% 331
2021
Q2 		$180M Buy
2,159,300
+547,100
+34% +$44.8M 0.04% 357
2021
Q1 		$121M Sell
1,612,200
-1,025,600
-39% -$74.7M 0.03% 500
2020
Q4 		$180M Buy
2,637,800
+59,900
+2% +$3.9M 0.05% 294
2020
Q3 		$151M Buy
2,577,900
+330,800
+15% +$20.6M 0.04% 284
2020
Q2 		$146M Buy
2,247,100
+326,000
+17% +$20.5M 0.05% 267
2020
Q1 		$114M Sell
1,921,100
-155,900
-8% -$10.4M 0.05% 295
2019
Q4 		$154M Sell
2,077,000
-804,900
-28% -$56.5M 0.07% 244
2019
Q3 		$182M Buy
2,881,900
+128,800
+5% +$7.63M 0.09% 179
2019
Q2 		$150M Sell
2,753,100
-196,400
-7% -$10.6M 0.07% 244
2019
Q1 		$159M Buy
2,949,500
+2,158,500
+273% +$133M 0.08% 203
2018
Q4 		$51.8M Buy
791,000
+153,200
+24% +$11.4M 0.03% 594
2018
Q3 		$50.2M Sell
637,800
-505,800
-44% -$36.2M 0.02% 757
2018
Q2 		$73.6M Buy
1,143,600
+291,400
+34% +$19.2M 0.04% 502
2018
Q1 		$53M Buy
852,200
+51,500
+6% +$3.7M 0.03% 568
2017
Q4 		$58.1M Buy
800,700
+234,700
+41% +$17.1M 0.04% 543
2017
Q3 		$46M Sell
566,000
-106,600
-16% -$8.43M 0.04% 591
2017
Q2 		$54.1M Sell
672,600
-276,400
-29% -$21.8M 0.05% 468
2017
Q1 		$74.5M Sell
949,000
-256,300
-21% -$20.5M 0.07% 280
2016
Q4 		$95.1M Buy
1,205,300
+600,100
+99% +$48.6M 0.1% 181
2016
Q3 		$53.9M Buy
605,200
+224,000
+59% +$21.1M 0.05% 354
2016
Q2 		$36.5M Buy
381,200
+92,300
+32% +$9.2M 0.04% 471
2016
Q1 		$30M Sell
288,900
-86,600
-23% -$8.42M 0.04% 526
2015
Q4 		$36.7M Sell
375,500
-2,800
-0.7% -$274K 0.04% 534
2015
Q3 		$36.5M Buy
378,300
+115,000
+44% +$12.1M 0.03% 569
2015
Q2 		$27.6M Buy
263,300
+58,000
+28% +$5.93M 0.02% 808
2015
Q1 		$21.2M Sell
205,300
-22,700
-10% -$2.3M 0.02% 946
2014
Q4 		$22M Buy
228,000
+109,800
+93% +$9.67M 0.02% 875
2014
Q3 		$9.41M Sell
118,200
-17,100
-13% -$1.35M 0.01% 1414
2014
Q2 		$10.2M Sell
135,300
-81,500
-38% -$6.16M 0.01% 1253
2014
Q1 		$16.2M Buy
216,800
+17,000
+9% +$1.2M 0.02% 950
2013
Q4 		$14.3M Sell
199,800
-46,100
-19% -$2.96M 0.02% 987
2013
Q3 		$14M Buy
245,900
+68,000
+38% +$4.05M 0.02% 911
2013
Q2 		$10.2M Buy
+177,900
New +$10.3M 0.02% 1055

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors's CVS Position: Q1 2026 in Review

Citadel Advisors increased its CVS Health (CVS) stake by 51% in Q1 2026, buying an estimated $141M and bringing the position to 5,428,043 shares worth $390M. The position accounts for 0.06% of the portfolio, ranked #233.

Citadel Advisors first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $564M in Q2 2025. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Citadel Advisors held 5,428,043 shares of CVS Health worth $390M as of Q1 2026.
  • Citadel Advisors bought 1,826,690 CVS Health shares in Q1 2026, an estimated $141M.
  • CVS Health made up 0.06% of Citadel Advisors's portfolio in Q1 2026, its #233 holding.
  • Citadel Advisors first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's CVS Health position peaked at $564M in Q2 2025.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.